|Número de publicación||US5171218 A|
|Tipo de publicación||Concesión|
|Número de solicitud||US 07/816,874|
|Fecha de publicación||15 Dic 1992|
|Fecha de presentación||2 Ene 1992|
|Fecha de prioridad||2 Ene 1992|
|También publicado como||DE69205441D1, DE69205441T2, EP0619745A1, EP0619745B1, US5330433, WO1993012826A1|
|Número de publicación||07816874, 816874, US 5171218 A, US 5171218A, US-A-5171218, US5171218 A, US5171218A|
|Inventores||James D. Fonger, Kenneth R. Jonkman|
|Cesionario original||Trustees Of Boston University, Dlp, Inc.|
|Exportar cita||BiBTeX, EndNote, RefMan|
|Citas de patentes (7), Otras citas (10), Citada por (81), Clasificaciones (10), Eventos legales (8)|
|Enlaces externos: USPTO, Cesión de USPTO, Espacenet|
U.S. application Ser. No. 07/600,483, filed on Oct. 19, 1990, titled PERCUTANEOUS TRANSSEPTAL LEFT ATRIAL CANNULATION SYSTEM.
In patients experiencing cardiopulmonary failure, a need exists to perfuse blood systemically. A femoral arterial cannula is typically used to infuse oxygenated blood into the body at the groin. To supply an adequate amount of oxygenated blood, the outer diameter of the cannula often occludes the inner diameter of the blood vessel as oxygenated blood is delivered through the lumen within the cannula. Blood exits the cannula from an opening at the distal end which typically directs blood toward the heart of the patient. For patients undergoing long-term cardiopulmonary assistance, the problem of ischemia in the lower extremity arises since the cannula blocks blood flow to the lower leg. A need exists to supply adequate blood flow to the lower leg tissues.
Prior attempts to obviate ischemia caused by arterial cannula occlusion have been awkward and inadequate. For example, the insertion of an arterial cannula in the aorta to avoid blockage has been suggested. Admittedly, the large diameter of the aorta permits the insertion of a large cannula without resulting in distal occlusion. However, such abdominal or thoracic surgery is invasive and more dangerous than the insertion of a cannula in a femoral artery. These dangers limit invasive techniques to only the most critically ill patients.
A second cannula can also be used to deliver blood to the lower leg when the femoral artery has been occluded by the systemic cannula. For example, a Y connector and tube could be inserted proximal to the occluding cannula and the distal end of the tube fitted with a catheter which is inserted into the femoral artery distal to the cannula. This also requires extra hardware and another cannulation.
A longstanding need exists for a bidirectional femoral arterial cannula which will deliver blood in both directions to maintain an adequate flow to the heart as well as in the direction of the lower extremity. The femoral arterial cannula of the invention achieves this bidirectional flow by means of a small diverting hole in the side of the cannula. The cannula comprises a first tube including a proximal end, a distal tip with an opening, a diverting side hole, and a barb on the tube exterior to position the diverting side hole away from the wall of the blood vessel such that fluid flowing in the first tube exits the distal tip opening in a first direction and exits the diverting side hole in a second direction. For example, blood is infused in the direction of the lower extremity through the diverting side hole and in the direction of the heart and body through the distal tip opening. The tube can be radiopaque to assist in positioning. However, the cannula can be properly positioned without resorting to fluoroscopic techniques. A cannula wall barb is positioned adjacent the diverting side hole. The barb permits the diverting side hole to be properly positioned in the blood vessel so as not to be occluded by the blood vessel wall. The proximal face of the barb has a steep slope which abuts the inner wall of the blood vessel and prevents the diverting side hole from occluding. The distal facing portion of the barb has a shallow slope which facilitates insertion of the barb into the blood vessel percutaneously over a guide wire.
The cannula further comprises a hub assembly connected to the proximal end of the first tube. The hub assembly includes a transparent flexible hub such that when the diverting side hole enters the blood vessel, blood flows into the hub region and provides a visual indication of the entry of the diverting side hole into the blood vessel. The cannula invention also includes a dilator assembly which is positioned inside the first tube. The dilator assembly is comprised of a distal end with a diameter which occludes the distal opening of the first tube. The proximal end of the dilator has a smaller diameter and serves as an obturator which stiffens the dilator assembly. The dilator assembly also includes a dilator hub which inserts into the hub assembly of the first tube such that a hollow passage is formed between the first and second tubes which allows blood from the diverting side hole to flow into the transparent hub assembly region. The dilator assembly further includes a guide wire channel within the second tube which allows for percutaneous insertion of the bidirectional cannula. As noted previously, the hollow passage serves as a flash chamber which provides a visual indication of when the diverting side hole enters the blood vessel. The hub assembly also includes a flange which can be used to fasten the entire cannula assembly to the patient's skin.
The addition of a diverting side hole, barb, and a hollow flash chamber for a visual indication of the entrance of the diverting side hole affords easy percutaneous insertion and proper placement of the bidirectional cannula in a femoral artery. The cannula is inserted into the femoral artery until the diverting side hole is inside of the blood vessel. At this point, blood flows into the transparent passage and flash chamber between the first and second tubes. This provides a positive visual indication to the physician that the diverting side hole is adequately within the blood vessel. The dilator assembly is then withdrawn and the proximal end of the cannula attached to a pump circuit. Thus, the distal end opening of the cannula provides systemic blood flow to the body while the diverting side hole provides blood flow to the leg. Ischemia and possible necrosis are thus avoided in patients undergoing extended cardiopulmonary assistance.
The above and other features of the invention including various novel details of construction and combinations of parts will now be more particularly described with reference to the accompanying drawings and pointed out in the claims. It will be understood that the particular device embodying the invention is shown by way of illustration only and not as a limitation of the invention. The principles and features of this invention may be employed in varied and numerous embodiments without departing from the scope of the invention.
FIG. 1 shows a side view of the cannula of the invention.
FIG. 2 shows a top view of the cannula of the invention.
FIG. 3 illustrates the dilator assembly of the cannula of the invention.
FIG. 4(a) shows the combined cannula and dilator assembly of the invention.
FIG. 4(b) illustrates the initial placement of the cannula of the invention in a femoral artery and the operation of the visual indicators of the cannula.
FIG. 5 shows a cross-sectional view of the cannula of FIG. 1.
FIG. 6 illustrates a longitudinal cross-sectional view of the cannula which encompasses the diverting side hole.
FIG. 7 illustrates a longitudinal cross-sectional view of the cannula which encompasses the protuberances.
FIG. 8 illustrates the operation of the cannula of the invention after the dilator assembly has been withdrawn and a blood pump attached.
FIG. 9 illustrates the distal flow output of a conventional unidirectional cannula.
FIG. 10 illustrates the distal flow of the bidirectional cannula of the invention.
FIG. 11 illustrates the distal pressure output of a conventional unidirectional cannula.
FIG. 12 illustrates the distal pressure output of a bidirectional cannula of the cannula.
FIG. 13 illustrates the mixed venous oxygen saturation (SVO2) of a conventional unidirectional cannula.
FIG. 14 illustrates the mixed venous oxygen saturation (SVO2) of the bidirectional cannula of the invention.
To prevent lower extremity ischemia and resulting tissue necrosis, the cannula of the invention supplies blood to both the body as well as in the opposite direction to the leg. FIG. 1 illustrates the simple construction of the bidirectional femoral arterial cannula. The cannula is comprised of a radiopaque polyurethane thin wall tube 112, with an outer diameter of 6 mm, which includes a tapered tip 110 with an opening for supplying blood to the main body of the patient. Tip 110 has an inner diameter of 4 mm and an outer diameter of 5 mm. Tube 112 can be typically 17 French or 14 French in width or other desired sizes as well. FIGS. 5, 6, and 7 illustrate the diverting side hole 38 for supplying blood to the lower extremity of the patient, and barb 36 for positioning the cannula diverting side hole within the blood vessel without blood vessel wall occlusion.
As shown in FIG. 7, barb 36 comprises a distal facing portion 39 with a shallow slope and a proximal facing portion 41 with a steep slope. The shallow slope of barb portion 39 facilitates insertion of the cannula into the artery. The steep slope of barb portion 42 abuts the inner wall of the blood vessel and properly positions the diverting side hole 38. Barb 36 is 1 cm in length and 1 mm in height. FIG. 5 illustrates the symmetrical placement of barbs 36, 5 mm apart, on either side of diverting side hole 38, which is located in a depression 43 on the exterior of the wall of cannula 112 and is 2 mm in diameter. As shown in FIG. 6, diverting side hole 38 is slanted with respect to the wall of cannula 112 and is less likely to be occluded in that position. FIG. 8 illustrates the placement of the cannula of the invention in a blood vessel for long term cardio-pulmonary patient support.
The proximal end 111 of cannula 112 is attached to a polyvinylchloride hub assembly 115. Hub assembly 115 includes a transparent flexible hub in segments 114, 116, and 22. As shown in FIG. 1, barb 36 is located 9 cm from tip 110 and 8.5 cm from hub 115. A short hub segment 114 is 1.5 cm in length. Hub segment 116 has a clamp area which is 3.5 cm in length extends from flange 118 to hub segment 114. As will be shown below, the transparent hub provides a visual indication of the entry of the diverting side hole into the blood vessel. The hub is connected to a rigid barbed connector 24 which can be coupled to standard 3/8" tubing. The hub also includes an air bleed inlet 2 with a screwable cap 20 which permits adjustment of the opening. Flanges 118 allow the hub assembly to be sewn or clamped onto the patient's skin and prevent unwanted movement of the cannula. Flanges 118 are shown in more detail in the top view of FIG. 2.
Dilator assembly 30 of FIG. 3 serves as an obturator or stiffener and is inserted into the interior of the cannula 112 and its associated hub assembly 115. The dilator assembly includes a second polyurethane tube 31 with a distal end 28, 9 cm in length, with a first diameter of 4 mm which occludes the first tube distal tip opening. The thickened portion of distal end 28 is 7.5 cm in length. Tapered tip 26 on second tube 31 facilitates insertion of the dilator assembly into the first tube of the cannula and dilates the guide wire hole in the vessel for cannula introduction. A polypropylene dilator hub with a tapered portion 32 seals inside of the rigid barbed connector 24 of hub assembly 115 and outer hub 34 is a handle for manipulation of the dilator. Portion 47 of second tube 31 is 20.5 cm in length and has a second diameter of 3 mm which is less than the first diameter. Thus, a hollow flash chamber is formed between the first and second tubes which allows blood entering the diverting side hole to flow into the hub assembly region. This provides the physician with a visual indication that the diverting side hole has entered the blood vessel. Only blood from the diverting side hole 38 can enter the flash chamber because the distal end 28 of second tube 31 occludes the distal end 110 of cannula 112. A guide wire 35 can also be introduced inside of the second tube 31 to guide the insertion of the cannula into the blood vessel.
The assembled cannula is shown in FIG. 4(a). FIG. 4(b) illustrates the operation of the visual indicator during the insertion of the cannula into the blood vessel. The diverting side hole 38 is shown resting on the wall of the blood vessel 40. Diverting side hole 38 is 1.5 cm from the thickened portion of distal end 28 of second tube 31. In this position, blood will fill the hollow chamber 37 between first tube 112 and second tube 31. The blood will flow into the transparent hub region and provide the physician with a visual indication of proper placement. The second tube 31 of dilator assembly 30 can also be of radiopaque plastic.
FIG. 4(b) also illustrates the placement of the cannula of the invention using barb 36 and diverting side hole 38. Skin 42 in the groin region is pierced using a conventional Seldinger needle. Tapered tip 26 on second tube 31 facilitates the dilation of the blood vessel. Cannula wall 112 is threaded into blood vessel 40 until the diverting side hole 38 enters the blood vessel. As noted previously, blood enters diverting side hole 38 and provides a visual indication in the area of the transparent hub as blood flows into hollow chamber 37. The dilator assembly also serves as an obturator or stiffener to assist in the introduction of the cannula. With air bleed hole 21 open, blood can easily flow into the flash chamber 37. The dilator assembly is then removed and rigid barb connector 24 is hooked up to standard 3/8" tubing connected to a blood pump circuit. The hub segment 116 is clamped after the dilatory assembly is removed. Once connector is attached to the blood pump tubing, the clamp can be removed from hub segment 116.
The bidirectional cannula of the invention provides adequate distal perfusion of the cannulated lower extremity. Thus, extended cardiopulmonary assistance can be provided with a greatly reduced risk of ischemia to the lower limb. The cannula of the invention can be used with any assist circuit. For example, the device could be attached to a percutaneous transseptal left atrial cannulation system. It can also be used for extracorporeal membrane oxygenation where heart function is adequate, but the lungs are failing. Any type of blood pump can be used with the cannula of the invention to provide a closed vascular circuit.
FIGS. 9-14 show the experimental data which illustrates the ability of the cannula of the invention to maximize pressure, flow, and oxygenation in the cannulated lower extremity. Experiments were performed on 200 pound pigs in which a conventional unidirectional cannula was inserted in one femoral artery and the bidirectional cannula of the invention was inserted in the other femoral artery. Flow probes and pressure catheters were positioned distal to the respective cannulae and measurements were taken over a spectrum of pump flows. Control values are with the pump turned off and before the cannulae are inserted into the femoral artery. FIG. 9 illustrates the distal flow in an extremity in which a conventional unidirectional cannula has been placed. As can be seen from FIG. 9, distal flow is non-existent in the lower extremity at all levels of perfusion. However, as shown in FIG. 10, when the bidirectional cannula of the invention is used, distal blood flow exceeds control values at full pump flow.
Similar data is produced when distal pressure is measured. For example, FIG. 11 illustrates the distal pressure associated the conventional unidirectional cannulation. Blood pressure is minimal even at high flows in the lower extremity. However, when a bidirectional cannula of the invention is used, blood pressure approaches the control value at full flow.
Finally, the mixed venous oxygen saturation (SVO2) was measured as an index of total limb perfusion, both directly from the cannula and also from native collateral vessels. Low SVO2 indicates poor perfusion and with a unidirectional cannula in place it indicates that collateral flow contributes very little to overall limb perfusion. Conversely, high SVO2 indicates good limb perfusion. The unidirectional cannula in FIG. 13 is associated with minimal direct or collateral flow whereas the bidirectional cannula in FIG. 14 produces almost a nominal SVO2 at high flows.
The bidirectional femoral arterial cannula of the invention provides adequate flow to the limb in cardiopulmonary assistance circuits used for long term applications. The barbed diverting side hole and blood flash chamber are simple to construct and easy to insert into the patient. Thus, a safe long term method for femoral artery cannulation is provided with minimal risk to the patient. Positioning can be accomplished percutaneously without resort to direct surgical exposure or fluoroscopic techniques because of the visual and tactile indications provided to the surgeon by the device.
Those skilled in the art will recognize, or be able to ascertain, using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. These and all other equivalents are intended to be encompassed by the following claims.
|Patente citada||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US1879249 *||7 Abr 1931||27 Sep 1932||Honsaker Charles Coy||Colonic tube|
|US3605750 *||7 Abr 1969||20 Sep 1971||David S Sheridan||X-ray tip catheter|
|US4114618 *||15 Dic 1976||19 Sep 1978||Vargas Jorge J||Catheter assembly|
|US4180068 *||13 Abr 1978||25 Dic 1979||Motion Control, Incorporated||Bi-directional flow catheter with retractable trocar/valve structure|
|US4863441 *||27 Ene 1988||5 Sep 1989||Minnesota Mining And Manufacturing Company||Venous return catheter|
|US4895564 *||8 Jun 1988||23 Ene 1990||Farrell Edward M||Percutaneous femoral bypass system|
|EP0139091A1 *||3 Jul 1984||2 May 1985||Abbott Laboratories||Catheter flashback indicator|
|1||Clarence Dennis, M.D. et al., "Clinical Use of a Cannula for Left Heart Bypass Without Thoracotomy; Experimental Protection Against Fibrillation by Left Heart Bypass," Annuls of Surgery, Oct. 1962, vol. 156, No. 1, pp. 623-637.|
|2||Clarence Dennis, M.D. et al., "Left Atrial Cannulation without Thoractomy for Total Left Heart Bypass," Acta Chir Scand, vol. 123, 1962, pp. 267-279.|
|3||*||Clarence Dennis, M.D. et al., Clinical Use of a Cannula for Left Heart Bypass Without Thoracotomy; Experimental Protection Against Fibrillation by Left Heart Bypass, Annuls of Surgery, Oct. 1962, vol. 156, No. 1, pp. 623 637.|
|4||*||Clarence Dennis, M.D. et al., Left Atrial Cannulation without Thoractomy for Total Left Heart Bypass, Acta Chir Scand, vol. 123, 1962, pp. 267 279.|
|5||J. Michael Duncan et al., "Rapid Placement of the Hemopump and Hemofiltration Cannula," Ann. Thorac. Surg., 1990; 50:667-669.|
|6||*||J. Michael Duncan et al., Rapid Placement of the Hemopump and Hemofiltration Cannula, Ann. Thorac. Surg., 1990; 50:667 669.|
|7||Lynn M. Pfaender, "Hemodynamics in the Extracorporeal Aortic Cannula: Review of Factors Affecting Choice of the Appropriate Size," The Journal of Extra-Corporeal Technology, vol. 13; No. 4 1981, pp. 224-232.|
|8||*||Lynn M. Pfaender, Hemodynamics in the Extracorporeal Aortic Cannula: Review of Factors Affecting Choice of the Appropriate Size, The Journal of Extra Corporeal Technology, vol. 13; No. 4 1981, pp. 224 232.|
|9||Robert Read, M.D. et al., "Improved Cannulation Method for Extracorporeal Membrane Oxygenation," Ann. Thorac. Surg., 1990; 50:670-671.|
|10||*||Robert Read, M.D. et al., Improved Cannulation Method for Extracorporeal Membrane Oxygenation, Ann. Thorac. Surg., 1990; 50:670 671.|
|Patente citante||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US5330433 *||18 Sep 1992||19 Jul 1994||Trustees Of Boston University||Bidirectional femoral arterial cannula|
|US5431639 *||12 Ago 1993||11 Jul 1995||Boston Scientific Corporation||Treating wounds caused by medical procedures|
|US5795325 *||11 Dic 1995||18 Ago 1998||Heartport, Inc.||Methods and apparatus for anchoring an occluding member|
|US5814016 *||7 Feb 1997||29 Sep 1998||Heartport, Inc.||Endovascular system for arresting the heart|
|US5830190 *||11 Jun 1996||3 Nov 1998||Becton Dickinson And Company||Protected needle catheter placement device having needle placement visualization features and method for its use|
|US5863366 *||15 Nov 1996||26 Ene 1999||Heartport, Inc.||Method of manufacture of a cannula for a medical device|
|US5879499 *||17 Jun 1996||9 Mar 1999||Heartport, Inc.||Method of manufacture of a multi-lumen catheter|
|US5976114 *||30 Abr 1998||2 Nov 1999||Medtronic, Inc.||Aortic cannula with reduced velocity flow-through tip|
|US6045531 *||22 Jul 1998||4 Abr 2000||Chase Medical Inc.||Catheter having a lumen occluding balloon and method of use thereof|
|US6068608 *||1 May 1997||30 May 2000||Chase Medical, Inc.||Method of using integral aortic arch infusion clamp|
|US6110145 *||14 Abr 1998||29 Ago 2000||Cardeon Corporation||Catheter system for surgical access and circulatory support of the heart|
|US6132397 *||1 May 1997||17 Oct 2000||Chase Medical Inc.||Integral aortic arch infusion clamp catheter|
|US6217546||19 May 1997||17 Abr 2001||United States Surgical Corporation||Catheter system|
|US6241699||22 Jul 1998||5 Jun 2001||Chase Medical, Inc.||Catheter system and method for posterior epicardial revascularization and intracardiac surgery on a beating heart|
|US6251093||13 Jul 1998||26 Jun 2001||Heartport, Inc.||Methods and apparatus for anchoring an occluding member|
|US6482171||13 Ene 1997||19 Nov 2002||Heartport, Inc.||Multi-lumen catheter|
|US6530876||25 Abr 2000||11 Mar 2003||Paul A. Spence||Supplemental heart pump methods and systems for supplementing blood through the heart|
|US6913600||25 Sep 1998||5 Jul 2005||Heartport, Inc.||Endovascular system for arresting the heart|
|US7025746||24 Dic 2002||11 Abr 2006||Yale University||Vascular access device|
|US7273446||1 Nov 2004||25 Sep 2007||Spence Paul A||Methods, devices and systems for counterpulsation of blood flow to and from the circulatory system|
|US7678132||7 Jun 2006||16 Mar 2010||Ovalis, Inc.||Systems and methods for treating septal defects|
|US7686805||1 Jul 2004||30 Mar 2010||Warsaw Orthopedic, Inc.||Methods for distraction of a disc space|
|US7686828||7 Jun 2006||30 Mar 2010||Ovalis, Inc.||Systems and methods for treating septal defects|
|US7722567||21 Dic 2005||25 May 2010||Yale University||Access device|
|US7722619||25 Abr 2006||25 May 2010||Warsaw Orthopedic, Inc.||Method of maintaining distraction of a spinal disc space|
|US7740640||28 May 2004||22 Jun 2010||Ovalis, Inc.||Clip apparatus for closing septal defects and methods of use|
|US7766813||20 Ago 2007||3 Ago 2010||Spence Paul A||Methods, devices and systems for counterpulsation of blood flow to and from the circulatory system|
|US7846179||1 Sep 2005||7 Dic 2010||Ovalis, Inc.||Suture-based systems and methods for treating septal defects|
|US7905823||29 Ago 2007||15 Mar 2011||Circulite, Inc.||Devices, methods and systems for establishing supplemental blood flow in the circulatory system|
|US7914530||25 Abr 2006||29 Mar 2011||Warsaw Orthopedic, Inc.||Tissue dilator and method for performing a spinal procedure|
|US7922696||24 Ene 2008||12 Abr 2011||Access Scientific, Inc.||Access device|
|US7993260||10 Nov 2009||9 Ago 2011||Thoratec Corporation||Implantable heart assist system and method of applying same|
|US7993378||6 Mar 2007||9 Ago 2011||Warsaw Orthopedic, IN.||Methods for percutaneous spinal surgery|
|US8070826||11 Dic 2003||6 Dic 2011||Ovalis, Inc.||Needle apparatus for closing septal defects and methods for using such apparatus|
|US8105286||18 Abr 2008||31 Ene 2012||Access Scientific, Inc.||Access device|
|US8157720||26 Ene 2007||17 Abr 2012||Circulite, Inc.||Heart assist system|
|US8192402||18 Abr 2008||5 Jun 2012||Access Scientific, Inc.||Access device|
|US8202251||13 Mar 2009||19 Jun 2012||Access Scientific, Inc.||Access device|
|US8257323||3 Ago 2005||4 Sep 2012||Medtronic, Inc.||Cannula system and method|
|US8333686||29 Ago 2007||18 Dic 2012||Circulite, Inc.||Cannula insertion devices, systems, and methods including a compressible member|
|US8343029||23 Oct 2008||1 Ene 2013||Circulite, Inc.||Transseptal cannula, tip, delivery system, and method|
|US8377006||11 Abr 2011||19 Feb 2013||Access Scientific, Inc.||Access device|
|US8388511||2 Dic 2011||5 Mar 2013||Paul A. Spence||Methods, devices and systems for counterpulsation of blood flow to and from the circulatory system|
|US8454549||20 Ene 2011||4 Jun 2013||Cardiacassist, Inc.||Method and system for closed chest blood flow support|
|US8460168||11 Jun 2013||Circulite, Inc.||Transseptal cannula device, coaxial balloon delivery device, and methods of using the same|
|US8545379||24 Jun 2008||1 Oct 2013||Circulite, Inc.||Cannula for heart chamber implantation and related systems and methods|
|US8545380||2 Mar 2009||1 Oct 2013||Circulite, Inc.||Intravascular blood pump and catheter|
|US8550973||9 Ene 2006||8 Oct 2013||Cardiacassist, Inc.||Percutaneous right ventricular assist apparatus and method|
|US8562519||31 Dic 2009||22 Oct 2013||Cardiacassist, Inc.||Pumping system and method for assisting a patient's heart|
|US8579936||21 Jun 2010||12 Nov 2013||ProMed, Inc.||Centering of delivery devices with respect to a septal defect|
|US8597258||27 Ago 2010||3 Dic 2013||Covidien Lp||Valved catheter|
|US8622949||8 Abr 2011||7 Ene 2014||Cardiacassist, Inc.||Method and system for closed chest blood flow support|
|US8657790||27 Oct 2011||25 Feb 2014||Access Scientific, Inc.||Access device with blunting device|
|US8663085||27 Feb 2013||4 Mar 2014||Paul A. Spence||Methods, devices and systems for counterpulsation of blood flow to and from the circulatory system|
|US8672888||25 May 2010||18 Mar 2014||Yale University||Access device|
|US8734447||27 Jun 2000||27 May 2014||Warsaw Orthopedic, Inc.||Apparatus and method of inserting spinal implants|
|US8747343||30 Sep 2011||10 Jun 2014||Covidien Lp||Hemodialysis catheter with improved side opening design|
|US8747483||16 Nov 2012||10 Jun 2014||ProMed, Inc.||Needle apparatus for closing septal defects and methods for using such apparatus|
|US8758401||30 Sep 2011||24 Jun 2014||ProMed, Inc.||Systems and methods for treating septal defects|
|US8795253 *||13 Mar 2012||5 Ago 2014||Sorin Group Italia S.R.L.||Bi-directional perfusion cannula|
|US8827958||12 May 2010||9 Sep 2014||Access Scientific, Llc||Access device with valve|
|US8900115||1 Jul 2011||2 Dic 2014||Thoratec Corporation||Implantable heart assist system and method of applying same|
|US8900192||18 Jul 2011||2 Dic 2014||Access Scientific, Llc||Access device|
|US8915884||22 Ene 2013||23 Dic 2014||Access Scientific, Inc.||Access device|
|US8956327||8 Feb 2011||17 Feb 2015||Access Scientific, Llc||Access device|
|US8979742||24 Sep 2013||17 Mar 2015||Cardiacassist, Inc.||Pumping system and method for assisting a patient's heart|
|US8992408||5 Sep 2013||31 Mar 2015||Cardiacassist, Inc.||Percutaneous right ventricular assist apparatus and method|
|US9005154||26 Sep 2008||14 Abr 2015||Covidien Lp||Valved hemodialysis catheter|
|US9044576||10 Ene 2013||2 Jun 2015||Covidien Lp||Catheter with valve|
|US9072867||30 Sep 2011||7 Jul 2015||Covidien Lp||Catheter with external flow channel|
|US9095649||16 Ene 2014||4 Ago 2015||Paul A. Spence||Methods, devices and systems for counterpulsation of blood flow to and from the circulatory system|
|US20040236331 *||1 Jul 2004||25 Nov 2004||Michelson Gary Karlin||Methods for distraction of a disc space|
|US20050096496 *||1 Nov 2004||5 May 2005||Spence Paul A.||Methods, devices and systems for counterpulsation of blood flow to and from the circulatory system|
|US20050148997 *||14 Feb 2005||7 Jul 2005||Valley Kirsten L.||Methods and apparatus for anchoring an occluding member|
|US20110112353 *||12 May 2011||Circulite, Inc.||Bifurcated outflow cannulae|
|US20120259273 *||11 Oct 2012||Mtmm Pty Ltd||Bi-Directional Perfusion Cannula|
|EP2574365A1 *||17 Sep 2012||3 Abr 2013||Covidien LP||Hemodialysis catheter with improved side opening design|
|EP2694148A1 *||4 Abr 2012||12 Feb 2014||MTMM PTY Ltd||Bi-directional perfusion cannula|
|EP2694148A4 *||4 Abr 2012||24 Dic 2014||Sorin Group Italia Srl||Bi-directional perfusion cannula|
|WO2007019262A2 *||3 Ago 2006||15 Feb 2007||Medtronic Inc||Cannula system and method|
|WO2012135904A1||4 Abr 2012||11 Oct 2012||Mtmm Pty Ltd||Bi-directional perfusion cannula|
|Clasificación de EE.UU.||604/164.02|
|Clasificación internacional||A61M25/00, A61M25/08, A61M25/04, A61M1/14, A61M25/06|
|Clasificación cooperativa||A61M25/007, A61M25/0606, A61M25/0693|
|2 Ene 1992||AS||Assignment|
Owner name: DLP, INC. A CORP. OF MICHIGAN, MICHIGAN
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:JONKMAN, KENNETH R.;REEL/FRAME:005980/0130
Effective date: 19911206
Owner name: TRUSTEES OF BOSTON UNIVERSITY, MASSACHUSETTS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:FONGER, JAMES D.;REEL/FRAME:005980/0126
Effective date: 19911212
|26 Oct 1993||CC||Certificate of correction|
|14 Nov 1994||AS||Assignment|
Owner name: MEDTRONIC, INC., MINNESOTA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DEVRIES, JAMES H., CHAIRMAN, DLP, INC.;REEL/FRAME:007203/0458
Effective date: 19940317
|6 Jun 1996||FPAY||Fee payment|
Year of fee payment: 4
|30 May 2000||FPAY||Fee payment|
Year of fee payment: 8
|30 Jun 2004||REMI||Maintenance fee reminder mailed|
|30 Nov 2004||SULP||Surcharge for late payment|
Year of fee payment: 11
|30 Nov 2004||FPAY||Fee payment|
Year of fee payment: 12